Greenland Mines Ltd. Common Stock vs. Halozyme Therapeutics, Inc.
GRML
Greenland Mines Ltd. Common Stock
$8.74 -13.76%
VS HALOHalozyme Therapeutics, Inc.
$107.44 -0.67%
Greenland Mines Ltd. Common Stock and Halozyme Therapeutics, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| GRML | HALO | |
|---|---|---|
| Market Cap | $643,980 | $12.28 billion |
| Revenue (TTM) | — | $1.66 billion |
| Net Income (TTM) | — | $413.60 million |
HALO leads on 1 of 1 size & scale factors.
Valuation
| GRML | HALO | |
|---|---|---|
| P/E Ratio | — | 31.42 |
| Price / Book | — | 85.53 |
| Price / Sales | — | 7.38 |
GRML and HALO split the valuation factors evenly.
Profitability
| GRML | HALO | |
|---|---|---|
| Net Margin | — | 24.86% |
| Return on Equity | — | 288.13% |
GRML and HALO split the profitability factors evenly.
Risk & Sentiment
| GRML | HALO | |
|---|---|---|
| Short Interest | 3.13% | 9.79% |
GRML leads on 1 of 1 risk & sentiment factors.
Dig deeper: GRML overview, GRML financials, HALO overview, HALO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.